Your Best Stock
Markets › Compare › BMY vs LLY

BMY vs LLY

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
BMY · Bristol-Myers Squibb$60.90 ▼ 0.42%
LLY · Eli Lilly and Co$1,188.19 ▲ 3.23%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

95117140163185Sep 25, '25Mar 25, '26Sep 23, '26
  • BMY +49.5%
  • LLY +64.2%

Head to head

MetricBMYLLY
Price$60.90$1,188.19
Change today▼ 0.42%▲ 3.23%
Market cap$124.39B$1.12T
Return, 3 months+12.0%+6.5%
Return, year to date+16.7%+11.1%
Return, 1 year+44.5%+61.2%
P/E (TTM)13.439.9
P/B5.633.0
P/E percentile vs own 5y38th5th
Dividend yield4.12%0.54%
Revenue growth (YoY, latest qtr)+5.7%+47.7%
Net profit growth (YoY)+152.6%+25.3%
Gross margin70.2%83.4%
Operating margin28.1%49.7%
Net margin18.9%33.5%
Return on equity46.7%102.4%
Analyst target vs. price+11.5%+15.5%
Analyst buy share44%86%
RSI (14)3651
30-day volatility21.7%26.1%
Max drawdown, 1 year-12.5%-23.2%
Trend readLeaning bearishStrong uptrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • LLY is the largest of the group by market value.
  • LLY has returned the most over the past year.
  • BMY carries the lowest trailing P/E.
  • BMY pays the highest dividend yield.
  • LLY is growing revenue fastest.
  • LLY keeps the most profit per dollar of sales.
  • BMY has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top